Ulinastatin improves survival of septic mice by suppressing inflammatory response and lymphocyte apoptosis

Journal of Surgical Research

Volumn 182, Issue 2, 2013, Pages 296-302

  Huang, Na ^a   Wang, Fei ^b   Wang, Yingwei ^a   Hou, Jiong ^b   Li, Jinbao ^b   Deng, Xiaoming ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Sepsis; Treatment; Ulinastatin

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HISTOLOGY; LYMPHOCYTE COUNT; MALE; MORTALITY; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPSIS; SHAM PROCEDURE; SPLEEN; SURVIVAL; T LYMPHOCYTE; THERAPY;

ANIMALS; APOPTOSIS; CYTOKINES; GLYCOPROTEINS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MICE; MICE, INBRED C57BL; SEPSIS; SERINE PROTEINASE INHIBITORS; SPLEEN; THYMUS GLAND; WEIGHT LOSS;

EID: 84877713591     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.10.043     Document Type: Article

References (28)

1. D.C. Angus, W.T. Linde-Zwirble, and J. Lidicker Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 29 2001 1303
2. R.C. Bone Sir Isaac Newton, sepsis, SIRS, and CARS Crit Care Med 24 1996 1125
3. D. Annane, E. Bellissant, and J.M. Cavaillon Septic shock Lancet 365 2005 63
4. R.S. Hotchkiss, and I.E. Karl The pathophysiology and treatment of sepsis N Engl J Med 348 2003 138
5. M.J. Pugia, and J.A. Lott Pathophysiology and diagnostic value of urinary trypsin inhibitors Clin Chem Lab Med 43 2005 1
6. R. Tanaka, M. Fujita, and R. Tsuruta Urinary trypsin inhibitor suppresses excessive generation of superoxide anion radical, systemic inflammation, oxidative stress, and endothelial injury in endotoxemic rats Inflamm Res 59 2010 597
7. Y. Fang, P. Xu, and C. Gu Ulinastatin improves pulmonary function in severe burn-induced acute lung injury by attenuating inflammatory response J Trauma 71 2011 1297
8. P. Molor-Erdene, K. Okajima, and H. Isobe Inhibition of lipopolysaccharide-induced tissue factor expression in monocytes by urinary trypsin inhibitor in vitro and in vivo Thromb Haemost 94 2005 136
9. K. Inoue, H. Takano, H. Sato, R. Yanagisawa, and T. Yoshikawa Protective role of urinary trypsin inhibitor in lung expression of proinflammatory cytokines accompanied by lethal liver injury in mice Immunopharmacol Immunotoxicol 31 2009 446
10. H. Takano, K. Inoue, and A. Shimada Urinary trypsin inhibitor protects against liver injury and coagulation pathway dysregulation induced by lipopolysaccharide/D-galactosamine in mice Lab Invest 89 2009 833
11. M. Ueki, S. Taie, and K. Chujo Urinary trypsin inhibitor reduces inflammatory response in kidney induced by lipopolysaccharide J Biosci Bioeng 104 2007 315
12. C. Gao, Y. Liu, L. Ma, and S. Wang Protective effects of ulinastatin on pulmonary damage in rats following scald injury Burns 38 2012 1027
13. J.Y. Lee, J.Y. Chon, H.S. Moon, and S.J. Hong The effect of ulinastatin on hemostasis in major orthopedic surgery Korean J Anesthesiol 58 2010 25
14. T. Takubo, S. Kuwajima, and N. Tatsumi Human urinary trypsin inhibitor Nihon Rinsho 57 1999 593
15. A. Ayala, M.M. Perrin, J.M. Kisala, W. Ertel, and I.H. Chaudry Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators (interleukins-1 and -6 and tumor necrosis factor) Circ Shock 36 1992 191
16. N. Sato, S. Endo, and Y. Kimura Influence of a human protease inhibitor on surgical stress induced immunosuppression Dig Surg 19 2002 300
17. M.J. Pugia, R. Valdes Jr., and S.A. Jortani Bikunin (urinary trypsin inhibitor): structure, biological relevance, and measurement Adv Clin Chem 44 2007 223
18. R.J. Johnson, W.G. Couser, and C.E. Alpers The human neutrophil serine proteinases, elastase and cathepsin G, can mediate glomerular injury in vivo J Exp Med 168 1988 1169
19. J.A. Trapani Granzymes: a family of lymphocyte granule serine proteases Genome Biol 2 2001 reviews3014.1
20. C.M. Kam, D. Hudig, and J.C. Powers Granzymes (lymphocyte serine proteases): characterization with natural and synthetic substrates and inhibitors Biochim Biophys Acta 1477 2000 307
21. V. Afshar-Kharghan, and P. Thiagarajan Leukocyte adhesion and thrombosis Curr Opin Hematol 13 2006 34
22. O. Wiedow, and U. Meyer-Hoffert Neutrophil serine proteases: potential key regulators of cell signalling during inflammation J Intern Med 257 2005 319
23. T. Olejar, and K. Nouza Thrombin and trypsin receptors: the same mechanism of signalling on cellular surfaces Bratisl Lek Listy 100 1999 75
24. C.A. Gogos, E. Drosou, H.P. Bassaris, and A. Skoutelis Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options J Infect Dis 181 2000 176
25. R.S. Hotchkiss, S.B. Osmon, and K.C. Chang Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways J Immunol 174 2005 5110
26. Z.Q. Zhao, and J. Vinten-Johansen Myocardial apoptosis and ischemic preconditioning Cardiovasc Res 55 2002 438
27. Y.Z. Cao, Y.Y. Tu, and X. Chen Protective effect of Ulinastatin against murine models of sepsis: inhibition of TNF-alpha and IL-6 and augmentation of IL-10 and IL-13 Exp Toxicol Pathol 64 2012 543
28. Y.J. Zhang, M. Li, M. Meng, M. Feng, and C.Y. Qin The effect of ulinastatin on the small intestine injury and mast cell degranulation in a rat model of sepsis induced by CLP Exp Toxicol Pathol 61 2009 481